Shin-Jr Tsai

Title: Innovations of Shin-Jr Tsai in Pharmaceutical Formulations

Introduction

Shin-Jr Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended-release medications. With a total of three patents to his name, Tsai's work focuses on improving the efficacy and duration of action of pharmaceutical compounds.

Latest Patents

One of Tsai's latest patents involves pharmaceutical formulations for the sustained release of sebacoyl dinalbuphine ester. This invention relates to injectable, extended-release pharmaceutical formulations that comprise a nalbuphine ester prodrug homogenously dissolved in a solution containing a pharmaceutically acceptable oil and an oil-miscible retaining solvent. The patent also outlines manufacturing processes and medical uses for these formulations. Furthermore, it provides methods for adjusting the duration of action by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Career Highlights

Throughout his career, Shin-Jr Tsai has worked with prominent companies in the pharmaceutical industry, including Lumosa Therapeutics Co., Ltd and Shanghai Lumosa Therapeutics Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Tsai has collaborated with several professionals in his field, including Chan-Jung Li and David Chih-Kuang Chou. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Shin-Jr Tsai's innovative work in pharmaceutical formulations demonstrates his commitment to enhancing drug delivery systems. His contributions are significant in the ongoing quest for more effective medical treatments.